ImmunoGen to host a conference call to discuss its financial results

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Oct 22 2009

ImmunoGen, Inc. (Nasdaq:IMGN), a biotechnology company that develops targeted anticancer products, today announced that will host a conference call at 4:30 pm ET on Thursday, October 29, 2009 to discuss the Company’s financial results for the three-month period ended September 30, 2009 – the first quarter of ImmunoGen’s 2010 fiscal year. Management also will provide an update on the Company.

To access the live call by phone, dial 913-312-6698. Passcode is 6451192. The call also may be accessed through the Investor Information section of the Company’s website, www.immunogen.com. Following the live webcast, a replay of the call will be available at the same location through November 5, 2009.

Source:

http://www.immunogen.com/

Posted in:

Tags: , , , ,

Comments (0)

Suggested Reading

Milestone in diabetes treatment: Transgenic cow produces human insulin in milk
SolasCure Awarded £405K Innovate UK Biomedical Catalyst Grant to Advance Chronic Wound Care
Insilico Medicine's AI-driven approach yields promising PTPN2/N1 inhibitor for cancer immunotherapy
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Study reveals association between ribosomal DNA copy number and disease risk
Sino Biological finalizes the acquisition of SignalChem Biotech, strengthening global presence and expanding product portfolio
UNIGE's synthetic anticoagulant provides reliable alternative to heparin
AI-driven model identifies potent cancer-killing immune cells for personalized immunotherapy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Longitudinal multi-omics monitoring paves the way for early pancreatic cancer diagnosis